Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong

Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 17, 2025

Keywords

ClinConnect Summary

This study is looking at different treatments for a serious condition called acute pulmonary embolism, which happens when a blood clot blocks blood flow in the lungs. The research focuses on two types of catheter-based therapies—treatments that use thin tubes inserted into the blood vessels to remove or break up clots. One method uses medicine delivered directly to the clot to dissolve it, and the other physically removes the clot using special devices. The goal is to see which approach works better and is safer for patients.

People who might join the study are adults diagnosed with acute pulmonary embolism and who receive any catheter-based treatment for this condition while in the hospital. There are no other restrictions, so most patients treated this way can be included. If you participate, your medical records will be reviewed to understand how well the treatment worked and whether there were any side effects. This study is currently recruiting patients in Hong Kong and aims to help doctors choose the best treatment for this life-threatening condition in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who is admitted with a diagnosis of acute pulmonary embolism
• • Patient who receives any types of catheter-based therapy for acute pulmonary embolism.
• Exclusion Criteria:
• • nil. This is a all-comer registry.